I suppose there’s a huge difference between deficient and denied. Your analysis sounds very plausible. There’s so much Generex has done for this application. Hopefully BARDA sees the light.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
